Skip to content
BOLUS

Signal from the log

Eyedentity AB

1,3 M EUR · Undisclosed · Sweden · Diagnostics

Fondée en 2025 à Stockholm, Eyedentity lit par apprentissage automatique les photographies du fond de l'oeil déjà prises en examen de routine chez l'opticien, pour trier les grains de beauté oculaires suspects. Son outil melAInoma vise le mélanome uvéal, dont les lésions bénignes sont bien plus fréquentes que la tumeur. La société dit réduire de 90 pour cent les faux positifs adressés au spécialiste, et prépare son marquage CE.

Verified

Announced on , logged by the watch of 21 August 2026.

Operation
Funding round
Announced amount
1,3 M EUR
Stage
Undisclosed
Country
Sweden
Sector
Diagnostics

What the log says

Editorial note, in French

Communiqué ouvert, montant relu et fonds nommés.

The investors

Led by Norrsken Launcher , with Karolinska Institutet Innovation

Provenance
Source eu-startups
Logged on 21 August 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.

One address, nothing else.

One letter a week, on Fridays: the week's funding rounds, the funds named, the amounts double checked. The list is never sold, one click to unsubscribe. The letter is written in French.

Email confirmation before any subscription. The list is never sold. What Bolus knows about you is written on the privacy page (in French).